logo-loader
viewTissue Regenix Group PLC

Tissue Regenix hit by cybersecurity breach

The incident is not believed to have impacted its UK operations or financial systems.

Tissue Regenix Group PLC -
Tissue specialises in skin, bone and organ grafts

AIM-listed regenerative medtech Tissue Regenix Group PLC (LON:TRX) has temporarily closed its manufacturing plant in Texas after a cybersecurity breach.

The incident involved unauthorised access to its computer systems and those of its third-party IT service provider in the United States. 

Investigations are underway using forensic cybersecurity experts with the company also working to quantify the potential financial impact and what is covered by its business disruption insurance.

The incident is not believed to have impacted its UK operations or financial systems.

Quick facts: Tissue Regenix Group PLC

Price: 0.351 GBX

AIM:TRX
Market: AIM
Market Cap: £24.69 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Tissue Regenix Group PLC named herein, including the promotion by the Company of Tissue Regenix Group PLC in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Tissue Regenix "advancing on many fronts" says CEO after SurgiPure FDA clearance

Antony Odell, chief executive at Tissue Regenix (LON:TRX), talks to Proactive Investors about the US FDA clearance for SurgiPure XD, a skin graft for hernias derived from pig tissue. The group, which already has experience of commercialising products in the US, is planning a commercial...

on 03/09/2016

2 min read